The review aims to explore novel medications for Duchenne muscular dystrophy and their effects on motor function and safety.
Reviewed existing literature on treatment options for Duchenne muscular dystrophy.
Evaluated mechanisms of action and safety profiles of the medications.
Analyzed evidence of impact on motor function.
Novel medications showed significant improvements in motor function in patients with DMD.
Safety considerations varied but were generally manageable with proper monitoring.
Evidence supports the use of these treatments for enhancing patient care in DMD.
Abstract
This review summarizes the mechanism of action, key safety considerations and available evidence on motor function impact that these novel medications have demonstrated in DMD.